Trials / Completed
CompletedNCT02493959
Degradation of the Anorexic Hormone Peptide YY
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Peptide YY (PYY) is a gastrointestinal hormone released from the enteroendocrine cell upon food intake. The N-terminal truncated form, PYY3-36, exerts anorexic effects. In this study we want to investigate the kinetics of PYY1-36 and PYY3-36 and to examine whether a C-terminally degraded metabolite, PYY3-34, is formed after infusion of PYY.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PYY1-36 infusion | Infusion of 1.6 pmol/kg/min PYY1-36 for 2 hrs. |
| BIOLOGICAL | PYY1-36 + sitagliptin | Infusion of 1.6 pmol/kg/min PYY1-36 for 2 hrs. Two doses of 100 mg sitagliptin are administered 10 and 1 hour before start of infusion, respectively. |
| BIOLOGICAL | PYY3-36 infusion | 0.8 pmol/kg/min infusion of PYY3-36. |
| BIOLOGICAL | placebo | Infusion of saline for 2 hrs. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2015-07-10
- Last updated
- 2015-07-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02493959. Inclusion in this directory is not an endorsement.